Types of Cancer

Pancreatic cancer

Director:
Prof. Michel Ducreux

Contact:
Phone: +33 (0)1 42 11 57 99
Email

Understanding the Disease

What is the pancreas?

The pancreas is the second-largest gland in the body. It is located in the upper abdomen, between the small intestine and the spleen, just behind the stomach, and plays a vital role in the digestion of fats and the regulation of blood sugar levels.
 

Pancreatic Cancer by the Numbers

  • 15,991

    new cases in 2023.

  • 71 years old

    Median age at diagnosis among men.

  • 74 years old

    median age at diagnosis among women. 

Prevention and Risk Factors

Symptoms

Diagnosis

Instadiag

The InstaDiag Pancreas Program

The InstaDiag Pancreas care pathway, developed and offered at Gustave Roussy, is designed to diagnose and treat pancreatic cancer. Gustave Roussy was selected by INCa as a pilot center for the implementation of this care pathway as part of a project to improve care pathways for cancers with a poor prognosis.

[Add a button linking to the InstaDiag Pancreas page]

Logo Instadiag

Treatments and Clinical Trials

The prognosis for pancreatic ductal adenocarcinoma is largely determined by the extent of the tumor. In the treatment of this condition, and depending on the stage of vascular invasion, three types of tumors are distinguished: resectable tumors (those that can be removed surgically), borderline resectable tumors (also called borderline), and unresectable tumors.

Join a clinical trial

Many clinical trials are open to patients with cancer. Participating in a clinical trial provides access to innovative treatments while contributing to the development of new therapies. 

Illustration microscope

Testimonial

Perrine's story: treated for pancreatic cancer at Gustave Roussy

I was diagnosed on June 11, and I was in the operating room on July 1. The surgery lasted eight hours. It was performed by Dr. Gelli, assisted by a robot, which left only three small incisions and allowed the tumor to be removed along with a significant portion of the pancreas. This was followed by a week in the hospital, marked by the compassion of the staff at Gustave Roussy, who showered me with small gestures of kindness, words of encouragement, and reassuring hand gestures that brought me great comfort. Trusting the teams and letting them take care of me helped dispel the anxiety that had consumed me since my diagnosis.

Search

Spotlight on the YODA Program

There has been an alarming increase in the incidence of gastrointestinal cancers, including pancreatic cancer, among young adults (patients aged 20 to 49). The vast majority of these patients are diagnosed at a metastatic stage and have a shorter survival time, since current screening guidelines are designed for older individuals.

Contact

Head of the Gastrointestinal Committee:
Prof. Michel Ducreux 

Contact
Tel.: +33 (0)1 42 11 57 99
avis.digestif@gustaveroussy.fr
 

  • Detecting Pancreatic Cancer Earlier for Better Treatment Outcomes

    Pancreatic cancer is the second most common digestive cancer. With a poor prognosis, it is often diagnosed at an inoperable stage and is therefore extremely difficult to treat in 90% of cases. One of the projects at the PRISM National Center for Precision Medicine aims to detect pancreatic cancer earlier in order to significantly increase patients’ chances of recovery. Ultimately, 100,000 lives could be saved each year worldwide.

    Médecins en réunion
  • Le lien entre consommation d’alcool et cancer du pancréas se précise

    Une consommation régulière d’alcool entraîne la baisse dans l’organisme de plusieurs lipides, qui pourrait être associée à un risque plus élevé de cancer du pancréas.

    Illustration pancréas
  • Pancreatic Cancer in 2025

    Challenges, Therapeutic Advances, and Future Prospects

    Ecran vidéo Michel Ducreux

Frequently Asked Questions